OB/GYN & Women’s Health

Selective vs. Universal NGS in Endometrial Cancer: A Cost-Efficiency Breakthrough

By MedXY 04/23/2026

A new study reveals that selective molecular profiling with MMR/p53 IHC followed by NGS for p53-abnormal tumors is more cost-efficient than universal NGS for advanced endometrial cancer, reducing unnecessary testing by 57%.

Cardiology news OB/GYN & Women’s Health

44% of Women with HDP Develop Chronic Hypertension Within 10 Years: Missed Opportunities in Postpartum Care

By MedXY 04/23/2026

A French cohort study reveals 44% of women receiving postpartum antihypertensives after HDP develop chronic hypertension within 10 years, signaling urgent gaps in long-term cardiovascular risk monitoring.

news OB/GYN & Women’s Health Pediatrics

Fetal Reduction in Triplet Pregnancies Significantly Reduces Neurodevelopmental Risks, Study Finds

By MedXY 04/23/2026

A nationwide cohort study reveals that fetal reduction from triplets to twins lowers the long-term risk of neurodevelopmental disorders in surviving children compared to non-reduced pregnancies.

news OB/GYN & Women’s Health Public Health

Hemorrhage, Hypertensive Disorders, and Infection Are the Leading Underlying Causes of Severe Maternal Morbidity, Study Finds

By MedXY 04/23/2026

A new hierarchical algorithm identifies hemorrhage, hypertensive disorders, and infection as the most common underlying conditions for severe maternal morbidity, differing significantly from causes of maternal mortality.

news OB/GYN & Women’s Health Oncology

Prophylactic Antibiotics Did Not Significantly Reduce Infection After Vulvar Surgery, Cohort Study Finds

By MedXY 04/20/2026

In a prospective cohort of 172 vulvar surgery patients, prophylactic antibiotics were not associated with fewer postoperative infections or complications, supporting the need for a randomized trial.

news OB/GYN & Women’s Health

A New Dutch Prediction Model Identifies Nulliparous Women at Higher Risk of Obstetric Anal Sphincter Injury

By MedXY 04/20/2026

A Dutch nationwide study developed and temporally validated two OASI risk models for nulliparous women, with moderate discrimination but excellent calibration. The models may help target counseling and preventive obstetric strategies.

news OB/GYN & Women’s Health

Biallelic ANAPC13 Mutations Identify a New Genetic Cause of Oocyte Maturation Arrest

By MedXY 04/20/2026

Biallelic ANAPC13 variants caused metaphase I oocyte maturation arrest in three women and in a knock-in mouse model, implicating APC/C dysfunction as a new monogenic cause of female infertility.

news OB/GYN & Women’s Health

Genetic Discovery: ANAPC13 Mutations Cause Female Infertility Through Oocyte Maturation Arrest

By MedXY 04/20/2026

Researchers identified biallelic ANAPC13 mutations as a genetic cause of female infertility characterized by oocyte maturation arrest. The study demonstrated how these mutations disrupt cell division in both humans and mice, and explored a potential mRNA-based treatment approach.

news OB/GYN & Women’s Health

ANAPC13 Mutations Emerge as a New Genetic Cause of Oocyte Maturation Arrest

By MedXY 04/20/2026

Biallelic ANAPC13 mutations were linked to metaphase I oocyte maturation arrest in humans and mice, implicating APC/C dysfunction as a new genetic cause of female infertility and a potential future target for rescue strategies.

General Surgery news OB/GYN & Women’s Health

2025 Guidelines for Managing Breast Infections and Inflammation: Key Updates and Expert Recommendations

By MedXY 04/14/2026

New multi-society guidelines provide evidence-based recommendations for managing lactational mastitis, granulomatous mastitis, and periductal mastitis with squamous metaplasia, addressing diagnostic challenges and treatment controversies.

news OB/GYN & Women’s Health Oncology

From 19 to 2: How a Simplified DNA Test Could Revolutionize Endometrial Cancer Detection

By MedXY 04/14/2026

Researchers successfully reduced a 19-marker DNA panel to just 2 methylated DNA markers that detect endometrial cancer with 96% sensitivity and 82% specificity using self-collected vaginal fluid, offering a less invasive alternative to endometrial biopsy.

news OB/GYN & Women’s Health

Timing Delivery for Large-for-Gestational-Age Fetuses: The Case for Earlier Induction

By MedXY 04/02/2026

A large cohort study of over 84,000 pregnancies reveals that induction at 38-39 weeks for large-for-gestational-age fetuses achieves comparable cesarean risk to spontaneous labor at 40 weeks, while avoiding the steep rise in complications beyond 40 weeks.

Diabetes & Endocrinology news OB/GYN & Women's Health OB/GYN & Women’s Health

Inpatient Postpartum Glucose Testing Triples Completion Rates After Gestational Diabetes

By MedXY 03/30/2026

A randomized controlled trial demonstrates that performing oral glucose tolerance tests before hospital discharge significantly improves screening rates and patient satisfaction compared to standard outpatient care for women with gestational diabetes.

news OB/GYN & Women’s Health

Clinical Trajectory of Early-Onset Severe Fetal Growth Restriction: Insights into Umbilical Artery Doppler Progression and Management

By MedXY 03/30/2026

This report examines the progression of Umbilical Artery Doppler abnormalities in 241 severe early-onset FGR cases, providing critical timelines for clinical deterioration, delivery planning, and fetal death risk assessment.

news OB/GYN & Women’s Health Oncology

Exploring Diagnostic Delays for Gynecologic and Breast Cancers Following Emergency Department Visits

By MedXY 03/23/2026

This study analyzes how cancer diagnosis timing varies after an emergency department visit, finding that breast cancer faces the longest delays while ovarian cancer is often diagnosed immediately. Factors like comorbidities and primary care access significantly influence these diagnostic intervals.

news OB/GYN & Women’s Health Public Health

Primary Cesarean Delivery Linked to Decreased Subsequent Fertility and Increased ART Utilization: A Decadal Population Study

By MedXY 03/23/2026

A large-scale retrospective cohort study involving nearly 300,000 women demonstrates that undergoing a cesarean delivery for a first birth is associated with an 11% lower likelihood of a second live birth and a 28% higher reliance on assisted reproductive technology for subsequent conception.

news OB/GYN & Women’s Health Psychiatry

Untreated Maternal Depression Linked to Increased Outpatient Opioid Use Following Cesarean Delivery

By MedXY 03/23/2026

A large multicenter study finds that while maternal depression does not affect inpatient opioid use after cesarean delivery, untreated depression significantly increases outpatient opioid consumption and perceived pain interference during the postpartum recovery period.

Diabetes & Endocrinology news OB/GYN & Women’s Health

Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus

By MedXY 03/22/2026

A groundbreaking machine learning study of over 37,000 patients identifies four distinct GDM phenotypic clusters. These findings demonstrate that early-diagnosed, high-comorbidity phenotypes carry a four-fold increased risk of postpartum diabetes, signaling a need for personalized clinical management in obstetric care.

Cardiology news OB/GYN & Women’s Health

Mechanical Heart Valves in Pregnancy: Navigating the High Risk of Thrombosis and the Biological Valve Advantage

By MedXY 03/20/2026

The ESC EORP ROPAC III registry highlights a stark contrast in pregnancy outcomes between mechanical and biological heart valves, revealing that only 54% of women with mechanical valves achieve an uncomplicated live birth, largely due to anticoagulation-related complications.

news OB/GYN & Women’s Health Oncology

Prioritizing Return of Value: A Roadmap to Enhancing Biobanking Participation Among Black Women with Endometrial Cancer

By MedXY 03/18/2026

This community-engaged mixed-methods study identifies critical Return of Value (ROV) elements, such as genetic insights and community health benefits, to improve biobanking engagement among Black women with endometrial cancer, offering 14 actionable recommendations for equitable translational research.